Evidence map›Paper›PMID 27184760›Full record

ReviewHuman vaccines & immunotherapeutics2016

Plasmodium falciparum gametocyte transit through the cutaneous microvasculature: A new target for malaria transmission blocking vaccines?

Christian P Nixon

Open access · bronzeAbstract readReview
In one paragraph

Review in Human vaccines & immunotherapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Zebra stripes: the questions raised by the answers.Biological reviews of the Cambridge Philosophical Society · 2025
    Review
  2. Article
  3. Article
  4. Targeting Gametocytes of the Malaria ParasitePathogens (Basel, Switzerland) · 2021
    Review
  5. Basic Research ofFrontiers in cellular and infection microbiology · 2021
    Review
  6. Article
  7. Review
  8. Article
  9. Uptake ofFrontiers in microbiology · 2020
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Christian P Nixona Center for International Health Research , Rhode Island Hospital and Alpert Medical School of Brown University , Providence , RI , USA.
Brown University · US

Funding

Statistics and Data Management P20GM104317 · NIGMS · UNIVERSITY OF RHODE ISLAND · PI MICHELOW, IAN · 2013 to 2017
$9.8M
NIGMS NIH HHS P20 GM104317
6 · The paper itself

Abstract

Malaria remains one of the most significant infectious diseases worldwide. Concordant with scaled intervention efforts and the emphasis of elimination and eradication on the agenda of many malaria control programs, the development of a malaria vaccine that reduces transmission of the parasite from human host to mosquito vector has been incorporated as an important new strategic goal. Transmission of malaria from man to mosquito relies on gametocytes, highly specialized sexual-stage parasites, that once mature, circulate in the peripheral vasculature of the human host. The complex interplay between mature gametocytes, their uptake in the mosquito bloodmeal and forward maturation/fertilization events provide unique opportunities for intervention. Although recent advances have yielded greater understanding into the mechanisms that mediate sequestration of immature gametocytes in the human host, the spatial dynamics of circulating mature gametocytes in the cutaneous microvaculature remains far less defined, which is the focus of this review.

Indexed as

AnimalsDisease Models, AnimalHumansMalaria, FalciparumMicrovesselsPlasmodium falciparumSkincutaneous microvasculaturegametocytesmalaria

Identifiers

PMID27184760
PMCPMC5215481
OpenAlexW2400114082

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.